| David C Novicki, DPM | |
|
32 Cherry St, Milford, CT 06460-3413 | |
| (203) 874-6755 | |
| (203) 877-7849 |
| Full Name | David C Novicki |
|---|---|
| Gender | Male |
| Speciality | Podiatry |
| Experience | 50 Years |
| Location | 32 Cherry St, Milford, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093789349 | NPI | - | NPPES |
| 0706090003 | Other | CT | MEDICARE DMERC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | 000133 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Milford Podiatry Associates Pc | 8123118056 | 4 |
News Archive
Every day, over 2.5 billion people suffer from a lack of access to improved sanitation and nearly 1.2 billion practise open defecation, the riskiest sanitary practice of all, according to a report issued today by the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. The programme is the official UN mechanism tasked with monitoring progress towards the Millennium Development Goals (MDG) Target 7c on drinking water supply and sanitation.
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.
Americans are split evenly on President Barack Obama's proposals for health care reform, according to a new poll released Wednesday. Still, a "CNN/Opinion Research Corporation survey indicates that a majority say (sic) it would be better to pass some sort of reform legislation than to leave the current health care system unchanged," CNN reports.
The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 9 days ago
| Provider Name | Yale University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1205822236 PECOS PAC ID: 9436061736 Enrollment ID: O20031105000015 |
News Archive
Every day, over 2.5 billion people suffer from a lack of access to improved sanitation and nearly 1.2 billion practise open defecation, the riskiest sanitary practice of all, according to a report issued today by the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. The programme is the official UN mechanism tasked with monitoring progress towards the Millennium Development Goals (MDG) Target 7c on drinking water supply and sanitation.
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.
Americans are split evenly on President Barack Obama's proposals for health care reform, according to a new poll released Wednesday. Still, a "CNN/Opinion Research Corporation survey indicates that a majority say (sic) it would be better to pass some sort of reform legislation than to leave the current health care system unchanged," CNN reports.
The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 9 days ago
| Provider Name | Northeast Medical Group Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20040123000522 |
News Archive
Every day, over 2.5 billion people suffer from a lack of access to improved sanitation and nearly 1.2 billion practise open defecation, the riskiest sanitary practice of all, according to a report issued today by the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. The programme is the official UN mechanism tasked with monitoring progress towards the Millennium Development Goals (MDG) Target 7c on drinking water supply and sanitation.
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.
Americans are split evenly on President Barack Obama's proposals for health care reform, according to a new poll released Wednesday. Still, a "CNN/Opinion Research Corporation survey indicates that a majority say (sic) it would be better to pass some sort of reform legislation than to leave the current health care system unchanged," CNN reports.
The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 9 days ago
| Provider Name | Milford Podiatry Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1437347754 PECOS PAC ID: 8123118056 Enrollment ID: O20071217000067 |
News Archive
Every day, over 2.5 billion people suffer from a lack of access to improved sanitation and nearly 1.2 billion practise open defecation, the riskiest sanitary practice of all, according to a report issued today by the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. The programme is the official UN mechanism tasked with monitoring progress towards the Millennium Development Goals (MDG) Target 7c on drinking water supply and sanitation.
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.
Americans are split evenly on President Barack Obama's proposals for health care reform, according to a new poll released Wednesday. Still, a "CNN/Opinion Research Corporation survey indicates that a majority say (sic) it would be better to pass some sort of reform legislation than to leave the current health care system unchanged," CNN reports.
The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David C Novicki, DPM 32 Cherry St, Milford, CT 06460-3413 Ph: (203) 874-6755 | David C Novicki, DPM 32 Cherry St, Milford, CT 06460-3413 Ph: (203) 874-6755 |
News Archive
Every day, over 2.5 billion people suffer from a lack of access to improved sanitation and nearly 1.2 billion practise open defecation, the riskiest sanitary practice of all, according to a report issued today by the WHO/UNICEF Joint Monitoring Programme for Water Supply and Sanitation. The programme is the official UN mechanism tasked with monitoring progress towards the Millennium Development Goals (MDG) Target 7c on drinking water supply and sanitation.
Mylan Inc., one of the world's leading generic and specialty pharmaceutical companies, today announced that its subsidiary in South Africa, Mylan (Proprietary) Limited, has launched a comprehensive portfolio of antiretroviral (ARV) products.
Americans are split evenly on President Barack Obama's proposals for health care reform, according to a new poll released Wednesday. Still, a "CNN/Opinion Research Corporation survey indicates that a majority say (sic) it would be better to pass some sort of reform legislation than to leave the current health care system unchanged," CNN reports.
The use of rapid point-of-care diagnostic tests for the measurement of CD4 T-cells, a marker of the immune system will be an important factor in improving the lives of people living with HIV and AIDS especially in developing and resource-poor countries.
Rutgers researchers are developing methods that can accurately assess the severity of prostate cancer by analyzing magnetic resonance images and spectra of a patient's prostate gland. This may help physicians decide more confidently which patients need aggressive treatment and which are better served by "watchful waiting," and could even postpone or eliminate invasive biopsies in patients with low-grade tumors.
› Verified 9 days ago
Sanjay Patel, D.P.M. Podiatrist Medicare: May Accept Medicare Assignments Practice Location: 309 Seaside Ave, Suite 202, Milford, CT 06460 Phone: 203-876-7736 | |
Complete Foot Care Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 140 Clark St, Milford, CT 06460 Phone: 203-877-6501 Fax: 203-876-1296 | |
Ian J Richter, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 309 Seaside Ave Ste 202, Milford, CT 06460 Phone: 203-876-7736 | |
Dr. Nili T Harpaz, DPM Podiatrist Medicare: Medicare Enrolled Practice Location: 309 Seaside Ave, Milford, CT 06460 Phone: 203-876-7736 | |
Milford Footcare Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 990 Bridgeport Avenue, Milford, CT 06460 Phone: 203-878-2642 Fax: 203-877-0849 | |
Dr. Karen A Borsos-debs, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 990 Bridgeport Ave, Milford, CT 06460 Phone: 203-878-2642 Fax: 203-877-0849 |